The Role of Topical Metronidazole in the Treatment of Rosacea

Cutis

Volumn 73, Issue 1 SUPPL., 2004, Pages 19-28

  Wolf Jr , John E ^a,b,c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Bioglan Pharmaceuticals   (United States)

^c Galderma Laboratories   (United States)

^d Dermatology Company   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DRUG VEHICLE; METROLOTION; METRONIDAZOLE; SUNSCREEN; TETRACYCLINE;

CLINICAL TRIAL; CONFERENCE PAPER; CREAM; DRUG ACTIVITY; DRUG DEGRADATION; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; GEL; HUMAN; INFLAMMATION; LOTION; PAPULE; ROSACEA; SIDE EFFECT; SKIN BURNING SENSATION; SKIN PENETRATION; SKIN SENSATION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; DICARBOXYLIC ACIDS; HUMANS; METRONIDAZOLE; ROSACEA;

EID: 0842287325     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Webster GF. Treatment of rosacea. Semin Cutan Med Surg. 2001;20:207-208.
2. Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis. 2000;66(suppl 4):7-13.
3. Wilkin JK. Rosacea. pathophysiology and treatment [editorial]. Arch Dermatol. 1994;130:359-362.
4. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144-150.
5. Bikowski JB. Rosacea: a tiered approach to therapy. Cutis. 2000;66(suppl 4):3-6.
6. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis. 2002;70:271-275.
7. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134:679-683.
8. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351.
9. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987;123:609-614.
10. Espagne E, Guillaume JC, Archimbaud A, et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea. Ann Dermatol Venereol. 1993;120:129-133.
11. Breneman D, Bucko A, Friedman D, et al. Evaluation of topical metronidazole lotion in rosacea. In: Abstracts of the American Academy of Dermatology 56th Annual Meeting; February 27-March 4, 1998; Orlando, Florida. Abstract P289.
12. Drake L, Leyden J, Lucky A, et al. Evaluation of topical metronidazole cream in rosacea. In: Abstracts of the American Academy of Dermatology 55th Annual Meeting; March 21-26, 1998; San Francisco, California. Abstract P65.
13. Bitar A, Bourgouin J, Doré N, et al. A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea. a placebo-controlled study. Drug Invest. 1990;2:242-248.
14. Bjerke JR, Nyfors A, Austad J, et al. Metronidazole (Elyzol) 1% cream v. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187-194.
15. Breneman DL, Stewart D, Hevia O, et al. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61:44-47.
16. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol. 1998;39:502-504.
17. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63-65.
18. McClellan KJ, Noble S. Topical metronidazole. a review of its use in rosacea. Am J Clin Dermatol. 2000;1:191-199.
19. Lowe NJ, Henderson T, Millikan LE, et al. Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Cutis. 1989;43:283-286.
20. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.
21. Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet. 1999;36:353-373.
22. Wagner N, Berthaud C, Laffet G, et al. Differential penetration of skin by topical metronidazole formulations. Adv Ther. 1998;15:197-205.
23. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48:836-845.
24. Elewski B. A comparison of topical azelaic acid 15% gel and metronidazole 0.75% gel in the treatment of papulopustular facial rosacea: results of a 15-week, randomized, double-blind, multicenter study. In: Abstracts of the American Academy of Dermatology 61st Annual Meeting; March 21-26, 2003; San Francisco, California. Abstract P50.